It is known that AR signaling is upregulated in prostate adenocarcinoma, including hormone-naïve and castration-resistant adenocarcinoma, and we further concluded that AR signaling maintains a high level in a less neuroendocrine-differentiated state that presented high NE signaling only but no pathological neuroendocrine features yet. This evidence concerns the gene AR and adenocarcinoma.